Muteins of fibroblast growth factor 21

Details for Australian Patent Application No. 2005283025 (hide)

Owner Eli Lilly and Company

Inventors Huang, Lihua; Micanovic, Radmila; Frye, Christopher Carl

Agent Spruson & Ferguson

Pub. Number AU-B-2005283025

PCT Pub. Number WO2006/028595

Priority 60/606,805 02.09.04 US

Filing date 26 July 2005

Wipo publication date 16 March 2006

Acceptance publication date 30 June 2011

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/028595 Priority application(s): WO2006/028595

30 June 2011 Application Accepted

  Published as AU-B-2005283025

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005283028-System and method for guiding navigation through a hypertext system

2005283023-System, method, and computer program product for content delivery in a push-to-talk communication system